Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.43 |
| ▸ | F2R | P25116 | 5/20 | 0.41 |
| ▸ | CTSL | P07711 | 3/20 | 0.37 |
| ▸ | UBE2M | P61081 | 3/20 | 0.37 |
| ▸ | DCUN1D1 | Q96GG9 | 3/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5135194 | 0.99 | C5AR1 (0.44) | C5AR1F2RCTSLUBE2MDCUN1D1 | |
| SCHEMBL5136483 | 0.96 | C5AR1 (0.43) | C5AR1F2RCTSLUBE2MDCUN1D1 | |
| SCHEMBL5135654 | 0.92 | C5AR1 (0.52) | C5AR1F2RHSP90AA1HSP90AB1BCHE | |
| SCHEMBL5137543 | 0.92 | C5AR1 (0.44) | C5AR1F2RCTSLUBE2MDCUN1D1 | |
| SCHEMBL5137123 | 0.92 | C5AR1 (0.44) | C5AR1F2RCTSLUBE2MDCUN1D1 | |
| SCHEMBL4763676 | 0.91 | C5AR1 (0.53) | C5AR1F2RUBE2MDCUN1D1HSP90AA1 | |
| SCHEMBL5135371 | 0.91 | C5AR1 (0.45) | C5AR1F2RCTSLUBE2MDCUN1D1 | |
| SCHEMBL5135260 | 0.91 | C5AR1 (0.44) | C5AR1F2RCTSLUBE2MDCUN1D1 | |
| SCHEMBL5137525 | 0.90 | C5AR1 (0.45) | C5AR1F2RCTSLUBE2MDCUN1D1 | |
| SCHEMBL5149996 | 0.90 | C5AR1 (0.49) | C5AR1F2RCTSLHSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |